K-Dur
K-Dur treats low potassium. We think.

Since 2003, the Federal Trade Commission has fought a losing battle to halt bargains in which a brand-name drug-maker pays a generic competitor to put off entering the market. Pacts like that, the agency urged, result in "reverse payments", which compensate a patent infringer not to do stuff that might infringe the patent. Such arrangements violate antitrust law

U.S. Senior District Judge John Padova today granted in part and denied in part the motion of Comcast for summary judgment on claims that it violated sections 1 and 2 of the Sherman Act by entering into market-allocation agreements with competitors and monopolizing the market for cable services in the Philadelphia area.

Judge Padova's 72-page

Blawgletter hasn't hidden our liking for the cut of the Second Circuit's jib. We admire lots of things about the court. This week, three panels confirmed our High Opinion.

Let's see . . . one involved whether an antitrust complaint met the Twombly/Iqbal standard for pleading a "plausible" conspiracy, the second dealt with